1-5 of 5
Ron McCord
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Determinants of Response to Mosunetuzumab Plus CHOP in Patients with Previously Untreated (1L) Diffuse Large B Cell Lymphoma (DLBCL)

Habib Hamidi, Patrick Kimes, Aaron Schroeder, Jasmina Uzunovic, Adam J Olszewski, Jason Sit, Enkhtsetseg Purev, Donald Yee, Ron McCord
Journal: Blood
Blood (2023) 142 (Supplement 1): 2999.
https://doi.org/10.1182/blood-2023-177591
Published: 2023
Journal Articles

Glofitamab (Glofit) Plus R-CHOP Has a Favorable Safety Profile and Induces High Response Rates in Patients with Previously Untreated (1L) Large B-Cell Lymphoma (LBCL) Defined As High Risk By Circulating Tumor DNA (ctDNA) Dynamics: Preliminary Safety and Efficacy Results

Lorenzo Falchi, Fabrice Jardin, Corinne Haioun, Tomasz Wrobel, Judit Mészáros Joergensen, Mariana Bastos-Oreiro, Eric Mou, Joaquin Martinez-Lopez, L. Elizabeth Budde, Nancy L. Bartlett, Jan M. Zaucha, Alejandro Martin Garcia-Sancho, Rutanshu Shah, Nathan Rees, Ron McCord, Alexandra Bazeos, Maneesh Tandon, Michelle Doral, Ethan Troy-Barnes, Marcel Nijland
Journal: Blood
Blood (2023) 142 (Supplement 1): 858.
https://doi.org/10.1182/blood-2023-173953
Published: 2023
Journal Articles

Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA

Renee P Stokowski, Ehsan Tabari, Patrick Bogard, Coleen Hacker, Olga K Kameneva, Tieming Ji, Li Teng, Vladislava Melnikova, Ron McCord, Elizabeth A Punnoose, Robert Loberg, Junaid Shabbeer
Journal: Blood
Blood (2022) 140 (Supplement 1): 9257–9258.
https://doi.org/10.1182/blood-2022-162814
Published: 2022
Journal Articles

Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Adam J Olszewski, MD, Abraham Avigdor, MD, Sunil Babu, Itai Levi, MD, Uri Abadi, Houston Holmes, Matthew McKinney, Ron McCord, Yuying Xie, Cindy Chen, Kati Sarouei, Naseer Qayum, Carol O'Hear, Gila Sellam, Herbert Eradat
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–45.
https://doi.org/10.1182/blood-2020-136255
Published: 2020
Journal Articles

Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma

Genevive Hernandez, PhD, Ling-Yuh Huw, PhD, Anton Belousov, PhD, Deanna Wilson, MS, Hartmut Koeppen, MD PhD, Ron McCord, PhD, Kun Peng, PhD, Nancy L Bartlett, MD, Lihua E Budde, MD PhD, Sarit Assouline, MD, Loretta J. Nastoupil, MD MSc, Dok Hyun Yoon, MD PhD, Matthew J Matasar, MD, Brendan Bender, PhD, Antonia Kwan, MD PhD MRCPCH, Chi-Chung Li, PhD, Carol O'Hear, MD PhD, Shen Yin, PhD, Michael C Wei, MD PhD, Joanne I Adamkewicz, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1585.
https://doi.org/10.1182/blood-2019-123933
Published: 2019